SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy 2001 Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785795.
  • 2
    Reddy JN 1993 An Introduction to the Finite Element Method, 2nd ed. McGraw-Hill, New York, NY, USA.
  • 3
    Crawford RP, Cann CE, Keaveny TM 2003 Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone 33: 744750.
  • 4
    Faulkner KG, Cann CE, Hasegawa BH 1991 Effect of bone distribution on vertebral strength: Assessment with patient-specific nonlinear finite element analysis. Radiology 179: 669674.
  • 5
    Liebschner MA, Kopperdahl DL, Rosenberg WS, Keaveny TM 2003 Finite element modeling of the human thoracolumbar spine. Spine 28: 559565.
  • 6
    Homminga J, Weinans H, Gowin W, Felsenberg D, Huiskes R 2001 Osteoporosis changes the amount of vertebral trabecular bone at risk of fracture but not the vertebral load distribution. Spine 26: 15551561.
  • 7
    Cody DD, Gross GJ, Hou FJ, Spencer HJ, Goldstein SA, Fyhrie DP 1999 Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech 32: 10131020.
  • 8
    Hernandez CJ, Keaveny TM 2006 A biomechanical perspective on bone quality. Bone (in press).
  • 9
    Silva MJ, Keaveny TM, Hayes WC 1998 Computed tomography-based finite element analysis predicts failure loads and fracture patterns for vertebral sections. J Orthop Res 16: 300308.
  • 10
    Keyak JH, Rossi SA, Jones KA, Skinner HB 1998 Prediction of femoral fracture load using automated finite element modeling. J Biomech 31: 125133.
  • 11
    Ford CM, Keaveny TM, Hayes WC 1996 The effect of impact direction on the structural capacity of the proximal femur during falls. J Bone Miner Res 11: 377383.
  • 12
    Keyak JH, Kaneko TS, Tehranzadeh J, Skinner HB 2005 Predicting proximal femoral strength using structural engineering models. Clin Orthop Relat Res 437: 219228.
  • 13
    Lian KC, Lang TF, Keyak JH, Modin GW, Rehman Q, Do L, Lane NE 2005 Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women. Osteoporos Int 16: 642650.
  • 14
    McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF 2005 Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165: 17621768.
  • 15
    Richardson ML, Genant HK, Cann CE, Kolb FO, Ettinger B, Gordan GS 1985 Noninvasive assessment of skeletal mass. J Comput Assist Tomogr 9: 636638.
  • 16
    Crawford RP, Brouwers JEM, Keaveny TM 2004 Accurate prediction of vertebral strength using voxel-based non-linear finite element models. 50th Annual Orthopaedic Research Society Meeting, March 7–10, 2004, San Francisco, CA, USA.
  • 17
    Kopperdahl DL, Morgan EF, Keaveny TM 2002 Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone. J Orthop Res 20: 801805.
  • 18
    Ün K, Bevill G, Keaveny TM 2006 The effects of side-artifacts on the elastic modulus of trabecular bone. J Biomech 39: 19551963.
  • 19
    Kopperdahl DL, Pearlman JL, Keaveny TM 2000 Biomechanical consequences of an isolated overload on the human vertebral body. J Orthop Res 18: 685690.
  • 20
    Pearson D, Miller CG 2002 Clinical Trials in Osteoporosis. Springer, New York, NY, USA.
  • 21
    Silva MJ, Wang C, Keaveny TM, Hayes WC 1994 Direct and computed-tomography thickness measurements of the human, lumbar vertebral shell and end-plate. Bone 15: 409414.
  • 22
    Crawford RP, Keaveny TM 2004 Relationship between axial and bending behaviors of the human thoracolumbar vertebra. Spine 29: 22482255.
  • 23
    Sato M, Westmore M, Clendenon J, Smith S, Hannum B, Zeng GQ, Brommage B, Turner CH 2000 Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized Cynomologus macaques. Osteoporos Int 11: 871888.
  • 24
    Hayes W 1991 Biomechanics of cortical and trabecular bone: Implications for assessment of fracture risk. MowV, HayesW (eds.) Basic Orthopaedic Biomechanics, Raven Press, New York, NY, USA, 93142.
  • 25
    Myers ER, Wilson SE 1997 Biomechanics of osteoporosis and vertebral fracture. Spine 22(Suppl 24): 25S31S.
  • 26
    Bouxsein ML, Black DM, Muller J, Bilezikian J, Greenspan S, Ensrud K, Palermo L, Crawford PM, Rosen CJ, Keaveny TM 2005 Combining biomechanical measures of vertebral strength with estimates of spinal loading to assess the effects of osteoporosis therapies on vertebral fracture: A pilot study in PaTH. J Bone Miner Res 20: S1; 411S.
  • 27
    Mosekilde L, Mosekilde L, Danielsen CC 1987 Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone 8: 7985.
  • 28
    Mosekilde L, Mosekilde L 1986 Normal vertebral body size and compressive strength: Relations to age and to vertebral and iliac trabecular bone compressive strength. Bone 7: 207212.
  • 29
    Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR 2000 Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85: 41184124.
  • 30
    Bouxsein ML 2005 Determinants of skeletal fragility. Best Pract Res Clin Rheumatol 19: 897911.
  • 31
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M 2000 Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Miner Res 15: 721739.
  • 32
    Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD 2003 Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial. Bone 33: 522532.
  • 33
    Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE 1999 Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: Effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone 25: 613619.
  • 34
    Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH 2005 Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab 90: 15831587.
  • 35
    McBroom RJ, Hayes WC, Edwards WT, Goldberg RP, White AA 1985 Prediction of vertebral body compressive fracture using quantitative computed tomography. J Bone Joint Surg Am 67: 12061214.
  • 36
    Cheng XG, Nicholson PHF, Boonen S, Lowet G, Brys P, Aerssens J, VanderPerre G, Dequeker J 1997 Prediction of vertebral strength in vitro by spinal bone densitometry and calcaneal ultrasound. J Bone Miner Res 12: 17211728.
  • 37
    Ebbesen EN, Thomsen JS, Beck-Nielsen H, Nepper-Rasmussen HJ, Mosekilde L 1999 Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone 25: 713724.
  • 38
    Eriksson SA, Isberg BO, Lindgren JU 1989 Prediction of vertebral strength by dual photon absorptiometry and quantitative computed tomography. Calcif Tissue Int 44: 243250.
  • 39
    Edmondston SJ, Singer KP, Day RE, Price RI, Breidahl PD 1997 Ex vivo estimation of thoracolumbar vertebral body compressive strength: The relative contributions of bone densitometry and vertebral morphometry. Osteoporos Int 7: 142148.
  • 40
    Eswaran SK, Allen MR, Burr D, Keaveny TM 2006 Effect of risedronate treatment-induced changes in microarchitecture on trabecular bone strength-density characteristics. 52nd Annual Orthopaedic Research Society Meeting, March 19–22, 2006, Chicago, IL, USA.
  • 41
    Day JS, Ding M, Bednarz P, van der Linden JC, Mashiba T, Hirano T, Johnston CC, Burr DB, Hvid I, Sumner DR, Weinans H 2004 Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22: 465471.
  • 42
    Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, Quartuccio H, Florauanti C, Clair J, Brown E, Hayes WC, Rodan GA 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92: 25772586.
  • 43
    Muller R, Hannan M, Smith SY, Bauss F 2004 Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. J Bone Miner Res 19: 17871796.
  • 44
    Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD 2004 Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34: 736746.
  • 45
    Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH 2004 Teriparatide [PTH (1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 19: 623629.
  • 46
    Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM 2001 Intermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16: 157165.
  • 47
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16: 18461853.
  • 48
    Hernandez CJ, Gupta A, Keaveny TM 2006 A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res 21: 12481255.
  • 49
    Adams MA, Green TP, Dolan P 1994 The strength in anterior bending of lumbar intervertebral discs. Spine 19: 21972203.
  • 50
    Eswaran SK, Gupta A, Adams MF, Keaveny TM 2006 Cortical and trabecular load sharing in the human vertebral body. J Bone Miner Res 21: 307314.
  • 51
    Faulkner KG 2000 Bone matters: Are density increases necessary to reduce fracture risk? J Bone Miner Res 15: 183187.
  • 52
    Delmas PD, Seeman E 2004 Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34: 599604.
  • 53
    Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112: 281289.